Tengion Overview
- Founded
- 2003
- Status
- Public
- Employees
- 11
- Stock Symbol
- TNGNQ
Tengion General Information
Description
Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
GREY
Primary Office
- 3929 Westpoint Boulevard
- Suite G
- Winston-Salem, NC 27103
- United States
Tengion Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 229K |
Tengion Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2014 | FY 2013 31-Dec-2013 | FY 2012 31-Dec-2012 | FY 2011 31-Dec-2011 |
|---|---|---|---|---|
| EV | 21,804 | 2,588 | 6,175 | (2,938) |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (56,419) | (11,085) | (13,543) | (15,124) |
| Net Income | (64,426) | (18,927) | (16,929) | (19,061) |
| Total Assets | 9,621 | 25,724 | 12,435 | 17,817 |
| Total Debt | 34,122 | 26,952 | 11,269 | 4,987 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Tengion Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Tengion‘s full profile, request access.
Request a free trialTengion Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing
Biotechnology
Winston-Salem, NC
11
As of 2015
00000
000000 - 000
00000000
etur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
0000 000000000
South San Francisco, CA
00
As of 0000
00000
000000000
00000
0000000
liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
0000 000000000
San Diego, CA
00
As of 0000
00000
0000
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialTengion Competitors (21)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Surrozen | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 000000000 | 00000 |
| 0000000 | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 00000000000 | 00000 |
| 00000 0000000000 | Accelerator/Incubator Backed | Phoenix, AZ | 0000 | 000000000 - | 0000 | |
| 000 0000000000000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 00000000 | Venture Capital-Backed | Durham, NC | 000 | 00000 | 000000000 | 00000 |
Tengion Executive Team (12)
Tengion Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000-00000 000000000 00.0 | Self | Board Member | 000 0000 |
| 00000 000000 | Tengion | Chairman & Board Member | 000 0000 |
| 00000 00000000 00 | Self | Board Member | 000 0000 |
| 0000 000000 | Self | Chief Executive Officer & Board Member | 000 0000 |
| 0000000 00000 00 | Self | Board Member | 000 0000 |
Tengion Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial